Ondine Biomedical Inc (AIM:OBI) President and Chief Technology Officer Nicolas Loebel and Matt Ross, Vice President of Sales and Marketing joined Steve.
Ondine Biomedical presents research demonstrating high efficacy against Extensively Drug-Resistant (XDR) bacteria at ICPIC 2023Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has presented new research at the 2023 International Consortium on Prevention & Infection Control (ICPIC) in Geneva, demo.
Ondine Biomedical Inc on Thursday said a new study has proven its Steriwave photodisinfection technology highly effective against drug-resistant pathogens on human tissues.
The Vancouver-based life.
Ondine Biomedical has presented new research at the 2023 International Consortium on Prevention & Infection Control (ICPIC) in Geneva. The data demonstrated.